Submitted by dcc on Mon, 2023-12-18 15:21 Study Title: A Randomized Phase II Study of Tepotinib with or without Ramucirumab in Participants with MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)CIRB: Adult CIRB - Late Phase EmphasisLead Group: RTOGStatus: ActiveReview Status: Available to Open
